½ÃÀ庸°í¼­
»óǰÄÚµå
1519417

¼¼°èÀÇ Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ : ¾ÆÅ°ÅØÃĺ°, ÀÚÀå °­µµº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ±â¼úº°, Áö¿ªº°(2024-2032³â)

Magnetic Resonance Imaging Systems Market Report by Architecture, Field Strength, Application, End Use, Technology, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 138 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2023³â 78¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ¾ÕÀ¸·Î IMARC GroupÀº 2024³âºÎÅÍ 2032³â±îÁö 3.8%ÀÇ ¼ºÀå·ü(CAGR)À» º¸¿´À¸¸ç, 2032³â±îÁö ½ÃÀåÀº 110¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

Àڱ⠰ø¸í ¿µ»ó(MRI)Àº ÀÎü ³» Àå±â ¹× ¿¬Á¶Á÷ÀÇ 3Â÷¿ø(3D) ¿µ»óÀ» »ý¼ºÇÏ´Â µ¥ »ç¿ëµÇ´Â ºñħ½ÀÀûÀÎ ¿µ»ó ±â¼úÀ» ¸»ÇÕ´Ï´Ù. MRI ÀåÄ¡´Â Á¶Á¤ °¡´ÉÇÑ Ä§´ë¿Í ¿øÇü ÀÚ¼®À¸·Î µÑ·¯½ÎÀÎ µÎ²¨¿î Æ©ºê·Î ±¸¼ºµÇ¸ç,ÀÌ Æ©ºê¸¦ ÅëÇØ ÀÚ±âÀå°ú ÀüÆÄ¸¦ ȯÀÚÀÇ ¸ö¿¡ Àû¿ëÇÕ´Ï´Ù. »ó¼¼ÇÑ À̹ÌÁö¸¦ ¾òÀ» ¼ö ÀÖ¾î ³ú, »À, À¯¹æ, ½ÉÀå, ³»Àå, ôÃß ÀÌ»ó Áø´ÜÀÌ ¿ëÀÌÇÕ´Ï´Ù. MRI´Â ÀϹÝÀûÀ¸·Î ¾çÀüÀÚ ¹æ»ç¼± ´ÜÃþÃÔ¿µ¹ý(PET) ¹× ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ¹ý(CT)°ú ÇÔ²² »ç¿ëµÇ¸ç Àǻ簡 °üÀý, Àδë, ¿¬°ñ, ±ÙÀ°, ÈûÁÙ µîÀ» °Ë»çÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀå °æÇâ:

¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í ¼¼°è¿¡¼­ Áø´Ü ¼­ºñ½ºÀÇ µµÀÔÀÌ Áõ°¡ÇÏ´Â °ÍÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. MRI´Â Á¤Çü¿Ü°ú, ½ÉÀåÇ÷°ü ¹× ±âŸ Áúº´ÀÇ Á¶±â ¹ß°ßÀ» °¡´ÉÇϰÔÇϰí Ä¡·áÀÇ ¼º°ø·üÀ» Å©°Ô Çâ»ó½Ãŵ´Ï´Ù. ÀÌ ¶§¹®¿¡ ¼¼°è¿¡¼­ MRIÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ º´¸®¿¡ °É¸®±â ½¬¿î ³ë³â Àα¸ Áõ°¡µµ MRI ä¿ë È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ¾÷±×·¹ÀÌµå ¹× ½ÉÀå ½É¹Ú Á¶À²±â¿Í ȣȯµÇ´Â ÃÊÀüµµ ÀÚ¼®ÀÇ »ç¿ëÀ» Æ÷ÇÔÇÑ À̹Ì¡ ÀåÄ¡ÀÇ ´Ù¾çÇÑ ±â¼úÀû Áøº¸°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ó¸® ¼Óµµ¸¦ °¡¼ÓÈ­ÇÏ°í ¿öÅ©Ç÷ο츦 ÀÚµ¿È­ÇÏ´Â 3D ¹× 4D À̹Ì¡ÀÇ µµÀÔ°ú °°Àº ±â¼ú Çõ½Å°ú ¾çÁúÀÇ ÀÇ·á ½Ã¼³À» ´©±¸³ª ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇÑ Á¤ºÎÀÇ ´ëó°¡ ½ÃÀåÀ» ´õ¿í °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ¼¼°èÀÇ Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â?
  • 2024³âºÎÅÍ 2032³â±îÁö ¼¼°èÀÇ ÀÚ±â°ø¸í¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°èÀÇ Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ¼¼°è ½ÃÀå¿¡¼­ COVID-19ÀÇ ¿µÇâÀº?
  • Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ¼¼°è ½ÃÀå¿¡¼­ ¾ÆÅ°ÅØÃ³º° ±¸ºÐÀº?
  • ÀÚ±âÀå °­µµ¿¡ ±âÃÊÇÑ Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ¼¼°è ½ÃÀå ³»¿ªÀº?
  • ¼¼°èÀÇ Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°èÀÇ Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°è Àڱ⠰ø¸í ¿µ»ó(MRI) ½Ã½ºÅÛ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼®: ¾ÆÅ°ÅØÃ³

  • Æó¼â ½Ã½ºÅÛ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • °³¹æ ½Ã½ºÅÛ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ÀÚÀå °­µµº°

  • ÀúÀÚÀå °­µµ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÁßÀÚÀå °­µµ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • °íÀÚÀå °­µµ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • Á¾¾çÇÐ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½Å°æÇÐ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½ÉÀ庴ÇÐ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¼ÒÈ­±â ³»°ú
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±Ù°ñ°Ý
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª: ÃÖÁ¾ ¿ëµµº°

  • º´¿ø
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • À̹ÌÁö ¼¾ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦10Àå ½ÃÀå ºÐ¼® : ±â¼úº°

  • MR Ç÷°ü Á¶¿µ °Ë»ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • MR Á¤¸Æ Á¶¿µ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±â´ÉÀû MRI
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • MR ºÐ±¤ÇÐ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦11Àå ½ÃÀå ºÐ¼®: Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦12Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Aspect Imaging
    • Aurora Imaging Technology
    • Bruker
    • Canon Medical Systems
    • Esaote SPA
    • Fonar Corporation
    • GE Healthcare
    • Hitachi
    • Koninklijke Philips NV
    • Neusoft Medical Systems
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Siemens Healthineers
JHS 24.07.31

The global magnetic resonance imaging (MRI) systems market size reached US$ 7.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2032, exhibiting a growth rate (CAGR) of 3.8% during 2024-2032.

Magnetic Resonance Imaging (MRI) refers to a non-invasive imaging technique, which is used to produce three dimensional (3D) images of organs and soft tissues inside the human body. An MRI machine consists of an adjustable bed and a large tube surrounded by a circular magnet through which the machine applies a magnetic field and radio waves on the patient's body. It produces detailed images and facilitates diagnosis of abnormalities in the brain, bones, breasts, heart, internal organs and spine. The MRI is usually combined with positron emission tomography (PET) and computed tomography (CT) scans to assist the doctors in examining joints, ligaments, cartilage, muscles and tendons, which is useful for detecting various muscular and bone injuries.

Magnetic Resonance Imaging Systems Market Trends:

The increasing prevalence of chronic diseases, along with the rising adoption of diagnostic services across the globe, is one of the key factors driving the growth of the market. MRI enables the early detection of orthopedic, cardiovascular and other conditions, which substantially increases the success rates of the treatment. This has consequently favored the adoption of MRI procedures across the globe. Furthermore, the growing geriatric population, which is more susceptible to such medical conditions, is also contributing to their increased adoption. Various technological advancements in the imaging equipment, such as software upgrades and utilization of super-conducting magnets compatible with cardiac pacemakers, are favoring the market growth. Moreover, innovations such as the introduction of 3D and 4D imaging equipped with accelerated processing speed and automated workflow, coupled with government initiatives to make quality healthcare facilities accessible to all, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global magnetic resonance imaging (MRI) systems market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on architecture, field strength, application, end use and technology.

Breakup by Architecture:

Closed System

Open System

Breakup by Field Strength:

Low Field Strength

Mid Field Strength

High Field Strength

Breakup by Application:

Oncology

Neurology

Cardiology

Gastroenterology

Musculoskeletal

Others

Breakup by End Use:

Hospitals

Imaging Centers

Ambulatory Surgical Centers

Others

Breakup by Technology:

MR Angiogram

MR Venogram

Functional MRI

MR Spectroscopy

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Aspect Imaging, Aurora Imaging Technology, Bruker, Canon Medical Systems, Esaote S.P.A, Fonar Corporation, GE Healthcare, Hitachi, Koninklijke Philips NV, Neusoft Medical Systems, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Siemens Healthineers.

Key Questions Answered in This Report

  • 1. How big is the global Magnetic Resonance Imaging (MRI) systems market?
  • 2. What is the expected growth rate of the global Magnetic Resonance Imaging (MRI) systems market during 2024-2032?
  • 3. What are the key factors driving the global Magnetic Resonance Imaging (MRI) systems market?
  • 4. What has been the impact of COVID-19 on the global Magnetic Resonance Imaging (MRI) systems market?
  • 5. What is the breakup of the global Magnetic Resonance Imaging (MRI) systems market based on the architecture?
  • 6. What is the breakup of the global Magnetic Resonance Imaging (MRI) systems market based on the field strength?
  • 7. What is the breakup of the global Magnetic Resonance Imaging (MRI) systems market based on the application?
  • 8. What is the breakup of the global Magnetic Resonance Imaging (MRI) systems market based on the end use?
  • 9. What are the key regions in the global Magnetic Resonance Imaging (MRI) systems market?
  • 10. Who are the key players/companies in the global Magnetic Resonance Imaging (MRI) systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Magnetic Resonance Imaging (MRI) Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Architecture

  • 6.1 Closed System
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Open System
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Field Strength

  • 7.1 Low Field Strength
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Mid Field Strength
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 High Field Strength
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Neurology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Gastroenterology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Musculoskeletal
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Imaging Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Technology

  • 10.1 MR Angiogram
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 MR Venogram
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Functional MRI
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 MR Spectroscopy
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Aspect Imaging
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Aurora Imaging Technology
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bruker
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Canon Medical Systems
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 Esaote S.P.A
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Fonar Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 GE Healthcare
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Hitachi
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Koninklijke Philips NV
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Neusoft Medical Systems
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Siemens Healthineers
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦